13D/13G Filings - Context Therapeutics Inc. (CNTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-14
5:11 pm
Unchanged
2025-06-3013GContext Therapeutics Inc.
CNTX
Great Point Partners, LLC4,683,711
5.220%
0
(Unchanged)
Filing
History
2025-08-14
2:28 pm
Purchase
2025-06-3013GContext Therapeutics Inc.
CNTX
Avidity Partners Management LP9,126,176
9.900%
1,349,880increase
(+17.36%)
Filing
History
2025-05-15
4:44 pm
Unchanged
2025-03-3113GContext Therapeutics Inc.
CNTX
Great Point Partners, LLC4,683,711
5.220%
0
(Unchanged)
Filing
History
2025-05-15
08:38 am
Unchanged
2025-03-3113GContext Therapeutics Inc.
CNTX
Deep Track Capital LP7,419,355
8.270%
0
(Unchanged)
Filing
History
2025-05-09
1:08 pm
Unchanged
2025-03-3113GContext Therapeutics Inc.
CNTX
FRANKLIN RESOURCES INC
BEN
4,003,380
4.500%
0
(Unchanged)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-3113GContext Therapeutics Inc.
CNTX
Blue Owl Capital Holdings LP6,357,928
8.480%
946,638increase
(+17.49%)
Filing
History
2025-02-14
4:33 pm
Sale
2024-12-3113GContext Therapeutics Inc.
CNTX
Great Point Partners, LLC4,683,711
6.250%
-2,251,271decrease
(-32.46%)
Filing
History
2025-02-14
10:02 am
Unchanged
2024-12-3113GContext Therapeutics Inc.
CNTX
Avidity Partners Management LP7,776,296
9.900%
0
(Unchanged)
Filing
History
2025-02-14
06:27 am
Sale
2024-12-3113GContext Therapeutics Inc.
CNTX
Opaleye Management Inc.0
0.000%
-820,000decrease
(Position Closed)
Filing
History
2025-02-12
5:20 pm
Purchase
2024-12-3113GContext Therapeutics Inc.
CNTX
Lehr Martin A.1,595,742
2.100%
143,276increase
(+9.86%)
Filing
History
2025-01-27
12:55 pm
Purchase
2024-12-3113GContext Therapeutics Inc.
CNTX
FRANKLIN RESOURCES INC
BEN
4,003,380
5.300%
4,003,380increase
(New Position)
Filing
History
2025-01-08
4:07 pm
Purchase
2024-12-3113GContext Therapeutics Inc.
CNTX
MPM BIOIMPACT LLC14,705,882
16.400%
14,705,882increase
(New Position)
Filing
History
2024-11-14
5:31 pm
Unchanged
2024-09-3013GContext Therapeutics Inc.
CNTX
Avidity Partners Management LP7,776,296
9.900%
0
(Unchanged)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-3013GContext Therapeutics Inc.
CNTX
Blue Owl Capital Holdings LP5,411,290
7.220%
5,411,290increase
(New Position)
Filing
History
2024-11-14
4:52 pm
Sale
2024-09-3013GContext Therapeutics Inc.
CNTX
Great Point Partners, LLC6,934,982
9.250%
-484,373decrease
(-6.53%)
Filing
History
2024-11-06
5:08 pm
Unchanged
2024-09-3013GContext Therapeutics Inc.
CNTX
Hudson Bay Capital Management LP1,000,000
1.320%
0
(Unchanged)
Filing
History
2024-06-05
10:45 am
Purchase
2024-05-3113GContext Therapeutics Inc.
CNTX
Great Point Partners, LLC7,419,355
9.890%
7,419,355increase
(New Position)
Filing
History
2024-05-24
4:15 pm
Purchase
2024-05-0613GContext Therapeutics Inc.
CNTX
Nextech Crossover I GP S.a. r.l.7,419,355
9.900%
7,419,355increase
(New Position)
Filing
History
2024-05-13
10:37 am
Purchase
2024-05-0213GContext Therapeutics Inc.
CNTX
Avidity Partners Management LP7,776,296
9.900%
7,776,296increase
(New Position)
Filing
History
2024-05-10
4:00 pm
Purchase
2024-05-0213GContext Therapeutics Inc.
CNTX
Deep Track Capital LP7,419,355
9.890%
7,419,355increase
(New Position)
Filing
History
Goto 0, 1, Next